Literature DB >> 16165165

Pharmacokinetics and brain uptake of lactoferrin in rats.

Bin Ji1, Jun Maeda, Makoto Higuchi, Kaori Inoue, Hidetaka Akita, Hideyoshi Harashima, Tetsuya Suhara.   

Abstract

Lactoferrin (Lf) is an iron-binding glycoprotein belonging to the transferrin (Tf) family. Lf was reported to cross the blood brain barrier (BBB) via receptor-mediated transcytosis in an in vitro model of the BBB. In the present study, we compared the in vivo brain uptake of Lf with that of OX26, an anti-Tf receptor antibody, and Tf. These three proteins were radiolabeled with 125I and administered to rats by i.v. injection. We found that Lf was more rapidly eliminated from the blood compared with OX26 and Tf (The half-life of Lf was approximately 8 and 6 times shorter than that of OX26 and Tf, respectively; the area under the blood concentration-time curve of Lf was approximately 15 and 17 times smaller than that of OX26 and Tf, respectively), and mainly accumulated in the liver, spleen, and kidney. Markedly high brain uptake was observed for Lf relative to Tf and OX26. Lf might be useful as a ligand for facilitating drug delivery into the brain.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16165165     DOI: 10.1016/j.lfs.2005.05.085

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  24 in total

1.  Future prospects of nanoparticles on brain targeted drug delivery.

Authors:  C Chakraborty; B Sarkar; C H Hsu; Z H Wen; C S Lin; P C Shieh
Journal:  J Neurooncol       Date:  2008-12-02       Impact factor: 4.130

Review 2.  Brain iron toxicity: differential responses of astrocytes, neurons, and endothelial cells.

Authors:  Julie A Gaasch; Paul R Lockman; Werner J Geldenhuys; David D Allen; Cornelis J Van der Schyf
Journal:  Neurochem Res       Date:  2007-04-03       Impact factor: 3.996

3.  Optimized lactoferrin as a highly promising treatment for intracerebral hemorrhage: Pre-clinical experience.

Authors:  Xiurong Zhao; Marian Kruzel; Shun-Ming Ting; Guanghua Sun; Sean I Savitz; Jaroslaw Aronowski
Journal:  J Cereb Blood Flow Metab       Date:  2020-05-21       Impact factor: 6.200

4.  Self-assembled polymersomes conjugated with lactoferrin as novel drug carrier for brain delivery.

Authors:  Yuan Yu; Zhiqing Pang; Wei Lu; Qi Yin; Huile Gao; Xinguo Jiang
Journal:  Pharm Res       Date:  2011-10-07       Impact factor: 4.200

5.  In Vitro Study of Receptor-Mediated Silica Nanoparticles Delivery across Blood-Brain Barrier.

Authors:  Yang Song; Dan Du; Lei Li; Jun Xu; Prashanta Dutta; Yuehe Lin
Journal:  ACS Appl Mater Interfaces       Date:  2017-06-12       Impact factor: 9.229

6.  Effect of lactoferrin- and transferrin-conjugated polymersomes in brain targeting: in vitro and in vivo evaluations.

Authors:  Hui-le Gao; Zhi-qing Pang; Li Fan; Kai-li Hu; Bing-xian Wu; Xin-guo Jiang
Journal:  Acta Pharmacol Sin       Date:  2010-02       Impact factor: 6.150

Review 7.  Nanomaterial-based blood-brain-barrier (BBB) crossing strategies.

Authors:  Jinbing Xie; Zheyu Shen; Yasutaka Anraku; Kazunori Kataoka; Xiaoyuan Chen
Journal:  Biomaterials       Date:  2019-09-14       Impact factor: 12.479

Review 8.  Iron and intracerebral hemorrhage: from mechanism to translation.

Authors:  Xiao-Yi Xiong; Jian Wang; Zhong-Ming Qian; Qing-Wu Yang
Journal:  Transl Stroke Res       Date:  2013-12-21       Impact factor: 6.829

9.  Intra-peritoneal injection of polyclonal anti-interferon alpha antibodies cross the blood brain barrier and neutralize interferon alpha.

Authors:  A Sas; R Jones; W Tyor
Journal:  Neurochem Res       Date:  2008-05-07       Impact factor: 3.996

10.  In vivo Glioblastoma Therapy Using Targeted Liposomal Cisplatin.

Authors:  Maryam Sadat Ashrafzadeh; Azim Akbarzadeh; Amir Heydarinasab; Mehdi Ardjmand
Journal:  Int J Nanomedicine       Date:  2020-09-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.